SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-21-010868
Filing Date
2021-02-22
Accepted
2021-02-22 17:00:26
Documents
6
Period of Report
2021-03-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea136203-def14a_silopharma.htm DEF 14A 476400
2 GRAPHIC proxy_001.jpg GRAPHIC 9096
3 GRAPHIC proxy_002.jpg GRAPHIC 2194
4 GRAPHIC proxy_003.jpg GRAPHIC 1732
5 GRAPHIC proxy_004.jpg GRAPHIC 1563
6 GRAPHIC proxy_005.jpg GRAPHIC 2774
  Complete submission text file 0001213900-21-010868.txt   502351
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-54872 | Film No.: 21661146
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl